Daniel A. Artusi - Jan 1, 2022 Form 4 Insider Report for MAXLINEAR INC (MXL)

Role
Director
Signature
/s/ Connie Kwong, as Attorney-in-Fact
Stock symbol
MXL
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 04:41 PM
Previous filing
Dec 16, 2021
Next filing
Feb 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXL Common Stock Options Exercise $0 +6.55K +44.41% $0.00 21.3K Jan 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXL Restricted Stock Units Options Exercise $0 -6.55K -100% $0.00* 0 Jan 1, 2022 Common Stock 6.55K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
F2 Subject to the Reporting Person's continuing as a Director (as defined in the 2010 Equity Incentive Plan) through such date, one hundred percent (100%) of the RSUs subject to the award will vest on the earlier to occur of May 1, 2020 or the date immediately preceding the 2020 annual meeting of stockholders. Reporting Person deferred delivery of shares of Common Stock issuable upon the vesting of RSUs on May 1, 2020. On January 1, 2022, the deferred shares of Common Stock were delivered to the Reporting Person.